Zantac recall issues: Knowing the signs of... By James L. Ferraro | Zantac Recall | Last Modified on Feb 20, 2026 Read More
Food and Drug Administration issues Class I... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Zantac use is now linked to breast... By James L. Ferraro | Zantac Recall | Last Modified on Feb 21, 2026 Read More
Food and Drug Administration recalls: The dangers... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Some mesothelioma patients may qualify for this... By James L. Ferraro | Mesothelioma | Last Modified on Feb 20, 2026 Read More
Companies continue to be fined for exposing... By James L. Ferraro | Asbestos Exposure & Claims | Last Modified on Feb 20, 2026 Read More
Food and Drug Administration approves Elmiron label... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Does mesothelioma survival data provide an accurate... By James L. Ferraro | Mesothelioma | Last Modified on Feb 27, 2026 Read More
What is the FDA’s involvement in recalls? By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Asbestos is still a threat for many,... By James L. Ferraro | Asbestos Exposure & Claims | Last Modified on Feb 23, 2026 Read More
The FDA says this hand sanitizer could... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 23, 2026 Read More
Is a test used to diagnose mesothelioma... By James L. Ferraro | Mesothelioma | Last Modified on Feb 23, 2026 Read More